MV-LASV (V182-001)

· Themis Bioscience GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MV-LASV (V182-001), covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001) [Phase 1]